BDBM182866 US9676728, 12-D (B) (-)-2-(1-(2,6-dimethoxy-4-methylphenyl)-2,2,2-trifluoro-1-(methylamino)ethyl)-1H-benzo[d]imidazole-5-carbonitrile

SMILES CNC(c1nc2cc(ccc2[nH]1)C#N)(c1c(OC)cc(C)cc1OC)C(F)(F)F

InChI Key InChIKey=SFCGOOBMTFGCRB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 182866   

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM182866(US9676728, 12-D (B) (-)-2-(1-(2,6-dimethoxy-4-meth...)
Affinity DataIC50: 1.11E+4nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
Go to US Patent